Therapeutic Solutions International, Inc.
TSOI
$0.0001
$0.000.00%
OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.70K | 20.00K | 21.80K | 23.80K | 25.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.70K | 20.00K | 21.80K | 23.80K | 25.70K |
| Cost of Revenue | 4.40K | 6.70K | 7.50K | 10.60K | 7.10K |
| Gross Profit | 15.30K | 13.30K | 14.30K | 13.30K | 18.70K |
| SG&A Expenses | 1.96M | 399.70K | 629.00K | 419.50K | 327.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.98M | 424.00K | 695.10K | 580.60K | 483.10K |
| Operating Income | -1.96M | -404.00K | -673.20K | -556.80K | -457.30K |
| Income Before Tax | -2.04M | -463.60K | -764.30K | -479.30K | -602.90K |
| Income Tax Expenses | -- | 800.00 | -- | 1.50K | -- |
| Earnings from Continuing Operations | -2.04M | -464.40K | -764.30K | -480.70K | -602.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.03M | 74.30K | 179.10K | 53.20K | 800.00 |
| Net Income | -1.01M | -390.00K | -585.10K | -427.50K | -602.00K |
| EBIT | -1.96M | -404.00K | -673.20K | -556.80K | -457.30K |
| EBITDA | -1.88M | -327.10K | -596.30K | -475.70K | -380.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 4.91B | 4.51B | 3.95B | 3.71B | 3.29B |
| Average Diluted Shares Outstanding | 4.91B | 4.51B | 3.95B | 3.71B | 3.29B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |